Home
Carterra

Carterra Market Share Analysis for August 2026

Flow printing microfluidics with surface plasmon to deliver up to 100x the data in 10% of the time using 1% of the sample requirements.

Science and Education > Biology

Domaincarterra-bio.com

Year Founded2005

Employees51 - 200

Annual Revenue$15M - $25M

Carterra

Carterra (including company regionals)

carterra-bio.com

See more website traffic and engagement information

Carterra Revenue up to August 2026 is 15M - 25M

revenue generated by Carterra top domains

Carterra top domains revenue over 3 years

Revenue for Carterra top domains

carterra-bio.com15M - 25M

See more with Sales Intelligence

Total visits to Carterra's top domains

Understand Carterra market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

carterra-bio.com6.5K

See more with Sales Intelligence

Avg. visit duration in Carterra's top domains

Analyze Carterra engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

carterra-bio.com00:00:13

See more with Sales Intelligence

Avg. pageviews on Carterra's top domains

See how Carterra keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

carterra-bio.com1.90

See more with Sales Intelligence

Carterra top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Carterra

These are the website technologies, by industry, used by Carterra top domains

Advertising (9)

DoubleClick

Payment & Currencies (5)

Cart Functionality

Conversion & Analytics (4)

Google Analytics

Social (4)

Instagram

More Technologies

10

See all

News & Signals from Carterra

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCarterra, Inc. launched Origin-1 on Jan 1st '26.Here Carterra, Inc. present Origin-1, a generative AI platform that overcomes this by integrating epitope-conditioned all-atom structure generation, paired complementarity determining region sequence design, and a specialized co-folding-based scoring protocol to select antibody designs predicted to be high-confidence, specific binders with favorable developability.

NewsCarterra, Inc. recognized as Winner on Apr 8th '26.As part of their analysis, they asserted that wet lab experiments will likely increase as the use of AI permeates drug discovery workflows and labeled Carterra a "Winner" in providing novel technology in the following categories:

NewsCarterra, Inc. launches 48-channel HT-SPR platform for advanced label-free biomolecular screening and characterization.Carterra launches industry's first 48-channel HT-SPR platform for advanced label-free biomolecular screening and characterization.